Evidence map›Paper›PMID 29069585›Full record

ArticleCell reports2017

Absence of Carbohydrate Response Element Binding Protein in Adipocytes Causes Systemic Insulin Resistance and Impairs Glucose Transport.

Archana Vijayakumar, Pratik Aryal, Jennifer Wen, Ismail Syed, Reema P Vazirani, Pedro M Moraes-Vieira, Joao Paulo Camporez, Molly R Gallop, Rachel J Perry, Odile D Peroni and 4 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 78 papers.

0numbers the graph read from it
0cells of the map it votes in
78citing papers in PubMed
14.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

78 citing papers in PubMed, 136 citations in OpenAlex.

  1. Review
  2. Article
  3. Advances in Adipose Tissue Biology.Endocrine reviews · 2026
    Review
  4. Article
  5. Insulin Deficiency Exacerbates Muscle Atrophy and Osteopenia inInternational journal of molecular sciences · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Nutrients · 2025
    Article
  12. Mondo family proteins in diabetes.Frontiers in endocrinology · 2025
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

18 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Archana VijayakumarDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Pratik AryalDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Jennifer WenDepartment of Biochemistry, Weill Cornell Medical College, New York, NY 10065, USA.
Ismail SyedDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Reema P VaziraniDepartment of Biochemistry, Weill Cornell Medical College, New York, NY 10065, USA.
Pedro M Moraes-VieiraDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Joao Paulo CamporezDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Molly R GallopDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Rachel J PerryDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA.
Odile D PeroniDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA.
Gerald I ShulmanDepartment of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Cellular & Molecular Physiology, Yale University School of Medicine, New Haven, CT 06520, USA; Howard Hughes Medical Institute, Yale University School of Medicine, New Haven, CT 06520, USA.
Alan SaghatelianSalk Institute for Biological Studies, Clayton Foundation Laboratories for Peptide Biology, Helmsley Center for Genomic Medicine, La Jolla, CA 92037, USA.
Timothy E McGrawDepartment of Biochemistry, Weill Cornell Medical College, New York, NY 10065, USA.
Barbara B KahnDivision of Endocrinology, Diabetes and Metabolism, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston MA 02215, USA. Electronic address: bkahn@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · USCornell University · USHarvard University · USYale University · USHoward Hughes Medical Institute · USSalk Institute for Biological Studies · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Vanderbilt Mouse Metabolic Physiology CenterU24DK059637 · NIDDK · VANDERBILT UNIVERSITY · PI WASSERMAN, DAVID H · 2001 to 2015
$14.9M
Yale Mouse Metabolic Phenotyping CenterU24DK059635 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 2001 to 2015
$8.9M
Regulation of the biosynthesis of a novel class of anti-diabetic lipidsR01DK106210 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAHN, BARBARA B., SAGHATELIAN, ALAN · 2016 to 2024
$6.6M
Mechanisms of Lipid-Induced Hepatic Insulin ResistanceR01DK040936 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1989 to 2015
$5.1M
GLUCOSE TRANSPORTER REGULATION IN OBESITY AND DIABETESR01DK043051 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAHN, BARBARA B. · 1992 to 2020
$4.4M
Metabolic effects of adipose lipogenesisR01DK098002 · NIDDK · BETH ISRAEL DEACONESS MEDICAL CENTER · PI KAHN, BARBARA B., MCGRAW, TIMOTHY E · 2013 to 2016
$2.4M
NCATS NIH HHS UL1 TR001863NIDDK NIH HHS P30 DK020541NIDDK NIH HHS P30 DK045735NIDDK NIH HHS P30 DK057521NIDDK NIH HHS R01 DK040936NIDDK NIH HHS R01 DK043051NIDDK NIH HHS R01 DK098002NIDDK NIH HHS R01 DK106210NIDDK NIH HHS U24 DK059635NIDDK NIH HHS U24 DK059637
6 · The paper itself

Abstract

Lower adipose-ChREBP and de novo lipogenesis (DNL) are associated with insulin resistance in humans. Here, we generated adipose-specific ChREBP knockout (AdChREBP KO) mice with negligible sucrose-induced DNL in adipose tissue (AT). Chow-fed AdChREBP KO mice are insulin resistant with impaired insulin action in the liver, muscle, and AT and increased AT inflammation. HFD-fed AdChREBP KO mice are also more insulin resistant than controls. Surprisingly, adipocytes lacking ChREBP display a cell-autonomous reduction in insulin-stimulated glucose transport that is mediated by impaired Glut4 translocation and exocytosis, not lower Glut4 levels. AdChREBP KO mice have lower levels of palmitic acid esters of hydroxy stearic acids (PAHSAs) in serum, and AT. 9-PAHSA supplementation completely rescues their insulin resistance and AT inflammation. 9-PAHSA also normalizes impaired glucose transport and Glut4 exocytosis in ChREBP KO adipocytes. Thus, loss of adipose-ChREBP is sufficient to cause insulin resistance, potentially by regulating AT glucose transport and flux through specific lipogenic pathways.

Indexed as

Insulin Resistance3T3 CellsAdipocytesAnimalsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsCells, CulturedGlucoseGlucose Transporter Type 4LiverMaleMiceMice, Inbred C57BLMuscle, SkeletalNuclear ProteinsPalmitic AcidsStearic AcidsBasic Helix-Loop-Helix Leucine Zipper Transcription FactorsGlucoseGlucose Transporter Type 4Mlxipl protein, mouseNuclear ProteinsPalmitic AcidsSlc2a4 protein, mouseStearic AcidsTranscription Factorsadipose-carbohydrate response element binding proteinadipose tissue inflammationChREBPde novo lipogenesisglucose transportGlut4 traffickingPAHSApalmitic acid hydroxy stearic acidsystemic insulin resistance

Identifiers

PMID29069585
PMCPMC5771491
OpenAlexW2765630251

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.